Atsushi Miyamoto

Mr. Atsushi Miyamoto

Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Respiration
Verified
Journal Article
Closed access
PDF file
TNToshiyuki Nakai
Toshiyuki Nakai
TWTetsuya Watanabe
Tetsuya Watanabe
YKYuto Kaimi
Yuto Kaimi
KSKazuhiko Shiomi
Kazuhiko Shiomi
KAKanae Ando
Kanae Ando
TKTomoya Kawaguchi
Tomoya Kawaguchi
Background: Transbronchial cryobiopsy enables high-quality sample collection around the probe tip. Meanwhile, existing cryoprobes have less flexibility and a higher risk of bleeding. The ultrathin cryoprobe with a 1.1-mm diameter addresses these problems and allows specimens to be directly retrieved through the working channel of a thin bronchoscope. Objective: This study evaluated the diagnostic utility and safety of non-intubated cryobiopsy using an ultrathin cryoprobe added to conventional biopsy for diagnosing peripheral pulmonary lesions (PPLs). Methods: The data of patients who underwent conventional biopsy followed by non-intubated cryobiopsy to retrieve specimens through the thin bronchoscope’s working channel for diagnosing PPLs at Osaka Metropolitan University Hospital from July 2021 to June 2022 were retrospectively collected. They were analyzed to evaluate the diagnostic utility and safety of adding non-intubated cryobiopsy to conventional biopsy for PPLs. The characteristics of PPLs that obtain additional diagnostic benefits from cryobiopsy over conventional biopsy were also investigated. Results: The analysis included 113 patients. The diagnostic yields of conventional biopsy and non-intubated cryobiopsy were 70.8% and 82.3%, respectively (p = 0.009). The total diagnostic yield was 85.8%, higher than conventional biopsy alone (p < 0.001). Although one moderate bleeding occurred, no severe complications developed. The additional diagnostic benefits of non-intubated cryobiopsy over conventional biopsy were demonstrated when the radial endobronchial ultrasound (R-EBUS) showed “adjacent to” (60.3% vs. 82.8%, p = 0.017). Conclusions: Non-intubated cryobiopsy using an ultrathin cryoprobe has high diagnostic utility and safety for diagnosing PPLs, with additional diagnostic benefits over conventional biopsy depending on the R-EBUS image.

26 February 2025 in Respirology
Verified
Journal Article
Open access
YFYuichiro Furukawa
Yuichiro Furukawa
AMAtsushi Miyamoto
Atsushi Miyamoto
Kazuhisa AsaiKazuhisa Asai
Kazuhisa Asai
MTMasaya Tsutsumi
Masaya Tsutsumi
KHKaho Hirai
Kaho Hirai
TKTomoya Kawaguchi
Tomoya Kawaguchi
Background and Objective: Chronic obstructive pulmonary disease (COPD) is closely related to skeletal muscle dysfunction, and the evaluation of respiratory muscle function has recently been recommended. We aimed to investigate the effects of respiratory muscle dysfunction on clinical outcomes.Methods: We retrospectively reviewed the medical records of patients with COPD whose respiratory muscle strength was measured between June 2015 and December 2021. We then analysed the effects of respiratory muscle strength on moderate‐to‐severe exacerbations after adjusting for confounding factors, including sex, age, forced expiratory volume in 1‐s percent predicted, hand grip strength, and skeletal muscle mass index. We also compared the temporal relationship between respiratory and systemic skeletal muscle dysfunctions.Results: Respiratory muscle weakness (RMW) was observed in 48.1% (100) of the 208 patients. Low percent predicted maximal inspiratory pressure was an independent risk factor for moderate‐to‐severe exacerbations within 1 year in the Cox regression analysis (adjusted hazard ratio per 1 standard deviation increase, 0.521; 95% confidence interval, 0.317–0.856). Approximately half of the patients already exhibited RMW at the mild systemic skeletal muscle dysfunction, while those with sarcopenia had higher RMW rates. More patients with RMW experienced progressive systemic skeletal muscle dysfunction within 1 year compared to those without RMW.Conclusion: Lower respiratory muscle strength is associated with an increased risk of exacerbation. Respiratory muscle function could serve as a marker of disease status and early prognosis in COPD. image

1 November 2020 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
AMAtsushi Miyamoto
Atsushi Miyamoto
Kazuhisa AsaiKazuhisa Asai
Kazuhisa Asai
HKHideaki Kadotani
Hideaki Kadotani
NMNaomi Maruyama
Naomi Maruyama
HKHiroaki Kubo
Hiroaki Kubo
TKTomoya Kawaguchi
Tomoya Kawaguchi
Purpose: Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic consequence of chronic obstructive pulmonary disease (COPD) and is correlated with higher mortality. Ninjin’yoeito (NYT) is a Japanese herbal medicine used to treat athrepsia and anorexia and is reported to ameliorate weight loss and muscular dysfunction. Recent studies have shown that its crude components upregulate the peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α)-related pathway, which is involved in skeletal muscle functions. Here, we examined whether NYT improves skeletal muscle complications by upregulating PGC-1α in COPD model mice. Materials and Methods: Mice were divided into four groups: control, NYT, smoking, and smoking + NYT. The smoking and smoking + NYT groups were exposed to cigarette smoke for 60 min once daily. The mice in the NYT and smoking + NYT groups were fed an NYT-containing diet (3% w/w). We performed cellular analysis of bronchoalveolar lavage fluid, assessed pulmonary morphological changes, examined the expression of PGC-1α mRNA and protein in the gastrocnemius and soleus muscle, measured the hindlimb muscle volume with micro-computed tomography, and determined the myofiber proportion in soleus muscle after 12 weeks. Results: Cigarette smoke exposure resulted in reduced skeletal muscle volume and slow-twitch muscle fibers and development of pulmonary emphysema. NYT feeding induced partial recovery of the damaged alveolar wall; however, NYT did not ameliorate smoke-induced alveolar enlargement. These findings revealed that NYT did not have sufficient efficacy in suppressing pulmonary emphysema. On the other hand, PGC-1α expression in muscle tissue of the NYT-fed mice increased significantly, resulting in suppression of smoke-induced loss of muscle mass and alteration in the muscle fiber distribution. Conclusion: NYT increases PGC-1α expression in the muscle of COPD model mice and is involved in suppressing cigarette smoke-induced muscle complications. NYT may be a novel preventive and therapeutic medication for muscular dysfunctions in COPD.

21 January 2024 in Respirology
Verified
Journal Article
Closed access
TNToshiyuki Nakai
Toshiyuki Nakai
YMYuji Matsumoto
Yuji Matsumoto
TUTakahiro Ueda
Takahiro Ueda
YKYuko Kuwae
Yuko Kuwae
STSayaka Tanaka
Sayaka Tanaka
TTTakaaki Tsuchida
Takaaki Tsuchida

26 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
HKHideaki Kadotani
Hideaki Kadotani
Kazuhisa AsaiKazuhisa Asai
Kazuhisa Asai
AMAtsushi Miyamoto
Atsushi Miyamoto
KIKohei Iwasaki
Kohei Iwasaki
TKTakahiro Kawai
Takahiro Kawai
TKTomoya Kawaguchi
Tomoya Kawaguchi
The fermented soy product ImmuBalance contains many active ingredients and its beneficial effects on some allergic diseases have been reported. We hypothesized that ImmuBalance could have potential effects on airway inflammation in a murine model of asthma. Mice sensitized and challenged with ovalbumin developed airway inflammation. Bronchoalveolar lavage fluid was assessed for inflammatory cell counts and levels of cytokines. Lung tissues were examined for cell infiltration and mucus hypersecretion. Oral administration of ImmuBalance significantly inhibited ovalbumin-induced eosinophilic inflammation and decreased Th2 cytokine levels in bronchoalveolar lavage fluid (p < 0.05). In addition, lung histological analysis showed that ImmuBalance inhibited inflammatory cell infiltration and airway mucus production. Our findings suggest that supplementation with ImmuBalance may provide a novel strategy for the prevention or treatment of allergic airway inflammation.

21 April 2023 in Respiratory Investigation
Verified
Journal Article
Closed access
TKTakahiro Kawai
Takahiro Kawai
Kazuhisa AsaiKazuhisa Asai
Kazuhisa Asai
AMAtsushi Miyamoto
Atsushi Miyamoto
KYKazuhiro Yamada
Kazuhiro Yamada
YFYuichiro Furukawa
Yuichiro Furukawa
TKTomoya Kawaguchi
Tomoya Kawaguchi